190 related articles for article (PubMed ID: 19833820)
1. Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer.
Sher DJ; Tishler RB; Annino D; Punglia RS
Ann Oncol; 2010 May; 21(5):1072-7. PubMed ID: 19833820
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of PET-CT-guided management for locally advanced head and neck cancer.
Smith AF; Hall PS; Hulme CT; Dunn JA; McConkey CC; Rahman JK; McCabe C; Mehanna H
Eur J Cancer; 2017 Nov; 85():6-14. PubMed ID: 28881249
[TBL] [Abstract][Full Text] [Related]
3. PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer.
Mehanna H; McConkey CC; Rahman JK; Wong WL; Smith AF; Nutting C; Hartley AG; Hall P; Hulme C; Patel DK; Zeidler SV; Robinson M; Sanghera B; Fresco L; Dunn JA
Health Technol Assess; 2017 Apr; 21(17):1-122. PubMed ID: 28409743
[TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness Analysis of Elective Neck Dissection in Patients With Clinically Node-Negative Oral Cavity Cancer.
Acevedo JR; Fero KE; Wilson B; Sacco AG; Mell LK; Coffey CS; Murphy JD
J Clin Oncol; 2016 Nov; 34(32):3886-3891. PubMed ID: 27551113
[TBL] [Abstract][Full Text] [Related]
5. Economic analysis of FDG-PET-guided management of the neck after primary chemoradiotherapy for node-positive head and neck squamous cell carcinoma.
Pryor DI; Porceddu SV; Scuffham PA; Whitty JA; Thomas PA; Burmeister BH
Head Neck; 2013 Sep; 35(9):1287-94. PubMed ID: 22987817
[TBL] [Abstract][Full Text] [Related]
6. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.
Tan A; Adelstein DJ; Rybicki LA; Saxton JP; Esclamado RM; Wood BG; Lorenz RR; Strome M; Carroll MA
Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):435-40. PubMed ID: 17515501
[TBL] [Abstract][Full Text] [Related]
7. A cost-effectiveness analysis of positron emission tomography-computed tomography surveillance versus up-front neck dissection for management of the neck for N2 disease after chemoradiotherapy.
Rabalais A; Walvekar RR; Johnson JT; Smith KJ
Laryngoscope; 2012 Feb; 122(2):311-4. PubMed ID: 22252963
[TBL] [Abstract][Full Text] [Related]
8. Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer.
Gourin CG; Boyce BJ; Williams HT; Herdman AV; Bilodeau PA; Coleman TA
Laryngoscope; 2009 Nov; 119(11):2150-5. PubMed ID: 19544378
[TBL] [Abstract][Full Text] [Related]
9. Neck dissection can be avoided after sequential chemoradiotherapy and negative post-treatment positron emission tomography-computed tomography in N2 head and neck squamous cell carcinoma.
Loo SW; Geropantas K; Beadsmoore C; Montgomery PQ; Martin WM; Roques TW
Clin Oncol (R Coll Radiol); 2011 Oct; 23(8):512-7. PubMed ID: 21501953
[TBL] [Abstract][Full Text] [Related]
10. PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer.
Mehanna H; Wong WL; McConkey CC; Rahman JK; Robinson M; Hartley AG; Nutting C; Powell N; Al-Booz H; Robinson M; Junor E; Rizwanullah M; von Zeidler SV; Wieshmann H; Hulme C; Smith AF; Hall P; Dunn J;
N Engl J Med; 2016 Apr; 374(15):1444-54. PubMed ID: 27007578
[TBL] [Abstract][Full Text] [Related]
11. Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT.
Nayak JV; Walvekar RR; Andrade RS; Daamen N; Lai SY; Argiris A; Smith RP; Heron DE; Ferris RL; Johnson JT; Branstetter BF
Laryngoscope; 2007 Dec; 117(12):2129-34. PubMed ID: 17921898
[TBL] [Abstract][Full Text] [Related]
12. A cost-utility analysis comparing CT surveillance, PET-CT surveillance, and planned postradiation neck dissection for advanced nodal HPV-positive oropharyngeal cancer.
Fu TS; Scheffler P; Forner D; Noel CW; Huang SH; Gilbert RW; Goldstein DP; O'Sullivan B; Mehanna HM; Waldron J; de Almeida JR
Cancer; 2021 Sep; 127(18):3372-3380. PubMed ID: 34062618
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of para-aortic lymphadenectomy before chemoradiotherapy in locally advanced cervical cancer.
Lee JY; Kim Y; Lee TJ; Jeon YW; Kim K; Chung HH; Kim HJ; Park SM; Kim JW
J Gynecol Oncol; 2015 Jul; 26(3):171-8. PubMed ID: 25925292
[TBL] [Abstract][Full Text] [Related]
14. Elective neck dissection versus positron emission tomography-computed tomography-guided management of the neck in clinically node-negative early oral cavity cancer: A cost-utility analysis.
Noel CW; Forner D; Goldstein DP; Metser U; Ferris RL; Waldron J; de Almeida JR
Cancer; 2021 Jun; 127(12):1993-2002. PubMed ID: 33635537
[TBL] [Abstract][Full Text] [Related]
15. Planned post-chemoradiation neck dissection: significance of radiation dose.
Stenson KM; Huo D; Blair E; Cohen EE; Argiris A; Haraf DJ; Vokes EE
Laryngoscope; 2006 Jan; 116(1):33-6. PubMed ID: 16481805
[TBL] [Abstract][Full Text] [Related]
16. The role of CT and ¹⁸F-FDG PET in managing the neck in node-positive head and neck cancer after chemoradiotherapy.
Inohara H; Enomoto K; Tomiyama Y; Yoshii T; Osaki Y; Higuchi I; Inoue T; Hatazawa J
Acta Otolaryngol; 2009 Aug; 129(8):893-9. PubMed ID: 18839385
[TBL] [Abstract][Full Text] [Related]
17. N2 disease in patients with head and neck squamous cell cancer treated with chemoradiotherapy: is there a role for posttreatment neck dissection?
Cho AH; Shah S; Ampil F; Bhartur S; Nathan CO
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1112-8. PubMed ID: 19917924
[TBL] [Abstract][Full Text] [Related]
18. Lymph node positive head and neck carcinoma after curative radiochemotherapy: a long lasting debate on elective post-therapeutic neck dissections comes to a conclusion.
Hermann RM; Christiansen H; Rödel RM
Cancer Radiother; 2013; 17(4):323-31. PubMed ID: 23706533
[TBL] [Abstract][Full Text] [Related]
19. Response assessment by combined PET-CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy.
Passero VA; Branstetter BF; Shuai Y; Heron DE; Gibson MK; Lai SY; Kim SW; Grandis JR; Ferris RL; Johnson JT; Argiris A
Ann Oncol; 2010 Nov; 21(11):2278-2283. PubMed ID: 20430907
[TBL] [Abstract][Full Text] [Related]
20. Response evaluation after chemoradiotherapy for advanced nodal disease in head and neck cancer using diffusion-weighted MRI and 18F-FDG-PET-CT.
Schouten CS; de Graaf P; Alberts FM; Hoekstra OS; Comans EF; Bloemena E; Witte BI; Sanchez E; Leemans CR; Castelijns JA; de Bree R
Oral Oncol; 2015 May; 51(5):541-7. PubMed ID: 25725587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
